intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention
Using measurement of radioactivity excreted in the urine, a test result indicating uptake of B12 was considered conclusive, whereas a test result suggesting no uptake should be judged with caution
The compounds don't compete for binding sites, don't share metabolic pathways during clearance, and don't modulate the same downstream signaling cascades
When in doubt, coders should consult payer policies and specialtyspecific guidelines
Digital storage is acceptable if encrypted and access-controlled
However, we will be looking forward to novel local and systemic mechanisms, molecules and agents that would be able to improve this concept by pharmacological therapy